A closer look at phase 3 data on…
A closer look at phase 3 data on BioNTech and [...]
Close to two years after AbbVie…
Close to two years after AbbVie handed over $48 million [...]
ORLANDO, Fla.—The leader of…
ORLANDO, Fla.—The leader of Gilead’s Kite Pharma is sure that [...]
The industry’s mRNA alliance is…
The industry’s mRNA alliance is demanding steady FDA leadership, warning [...]
The FDA’s reported plan to move…
The FDA’s reported plan to move toward single-trial approvals has [...]
Encoded Therapeutics has linked…
Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 [...]
Having already claimed a win for…
Having already claimed a win for the phase 2 study [...]
Pfizer’s VC arm has backed a…
Pfizer’s VC arm has backed a $100 million series A [...]
The top spot at the FDA’s Center…
The top spot at the FDA’s Center for Drug Evaluation [...]
The FDA has placed a hold on…
The FDA has placed a hold on Denali Therapeutics’ plans [...]